Voltage-gated Ca 2؉ channels in arterial myocytes can mediate Ca 2؉ release from the sarcoplasmic reticulum and, thus, induce contraction without the need of extracellular Ca 2؉ influx. This metabotropic action of Ca 2؉ channels (denoted as calcium-channelinduced calcium release or CCICR) involves activation of G proteins and the phospholipase C-inositol 1,4,5-trisphosphate pathway. Here, we show a form of vascular tone regulation by extracellular ATP that depends on the modulation of CCICR. In isolated arterial myocytes, ATP produced facilitation of Ca 2؉ -channel activation and, subsequently, a strong potentiation of CCICR. The facilitation of L-type channel still occurred after full blockade of purinergic receptors and inhibition of G proteins with GDP␤S, thus suggesting that ATP directly interacts with Ca 2؉ channels. The effects of ATP appear to be highly selective, because they were not mimicked by other nucleotides (ADP or UTP) or vasoactive agents, such as norepinephrine, acetylcholine, or endothelin-1. We have also shown that CCICR can trigger arterial cerebral vasoconstriction in the absence of extracellular calcium and that this phenomenon is greatly facilitated by extracellular ATP. Although, at low concentrations, ATP does not induce arterial contraction per se, this agent markedly potentiates contractility of partially depolarized or primed arteries. Hence, the metabotropic action of L-type Ca 2؉ channels could have a high impact on vascular pathophysiology, because, even in the absence of Ca 2؉ channel opening, it might mediate elevations of cytosolic Ca 2؉ and contraction in partially depolarized vascular smooth muscle cells exposed to small concentrations of agonists.
C
ontraction of vascular smooth muscle cells (VSMCs) determines vessel diameter and, thus, regulates blood flow and pressure. VSMC contraction is triggered by a rise of cytosolic calcium ion concentration ([Ca 2ϩ ]) due to either transmembrane Ca 2ϩ influx or Ca 2ϩ release from the sarcoplasmic reticulum (SR). Extracellular Ca 2ϩ entry normally occurs through L-type voltagedependent Ca 2ϩ channels, although there are numerous ligandgated membrane channels that are also Ca 2ϩ permeable (1) . Ca 2ϩ release from the SR is mediated by inositol trisphosphate (InsP 3 ) and ryanodine receptors. Vasoactive agents acting on the different vascular territories induce VSMC contraction by binding to membrane receptors and the subsequent activation of one or more of the Ca 2ϩ -entry and͞or Ca 2ϩ -release channels (2-5). We have described a previously unnoticed metabotropic effect of vascular L-type Ca 2ϩ channels, denoted as calcium-channelinduced Ca 2ϩ release (CCICR), which requires Ca 2ϩ channel activation but is independent of extracellular Ca 2ϩ influx (6) . This new Ca 2ϩ -release mechanism depends on the conformational change of L-type Ca 2ϩ channels and the downstream activation of the G protein͞phospholipase C (PLC) cascade, leading to synthesis of InsP 3 and Ca 2ϩ release from the SR (6, 7) . Although CCICR can be triggered either by direct membrane depolarization in patchclamped myocytes or upon exposure of the cells to a high-K ϩ solution (6) , its actual physiological significance is unknown. This research was undertaken to study the possible synergistic interaction between CCICR and vasoactive agents and to evaluate the impact of CCICR on arterial contractility. It had been reported in several cell types (including arterial myocytes) that agonist-induced Ca 2ϩ release from internal stores can be modulated by the cell's membrane potential. However, this phenomenon was not associated with L-type Ca 2ϩ channel activation but was attributed to the existence of a voltage-dependent step in the PLC-activation͞InsP 3 synthesis pathway (8) (9) (10) . Here, we report that CCICR is, indeed, selectively regulated by low concentrations of extracellular ATP, an agent coreleased with norepinephrine (NE) from sympathetic terminals and from cells (erythrocytes and platelets) damaged during vascular injury (11) (12) (13) . Moreover, CCICR can produce arterial cerebral vasoconstriction in the absence of extracellular Ca 2ϩ influx, and this effect is greatly potentiated by subthreshold concentrations of ATP. Unexpectedly, ATP directly modifies Ltype Ca 2ϩ channel gating and, thus, increases both Ca 2ϩ -current amplitude and CCICR. This metabotropic action of L-type Ca 2ϩ channels could be of high relevance for vascular pathophysiology because, even in the absence of Ca 2ϩ channel opening, it might mediate elevations of cytosolic Ca 2ϩ and protracted contraction in partially depolarized VSMCs exposed to small concentrations of agonists.
Results
Extracellular ATP Potentiates Ca 2؉ Channel-Induced Ca 2؉ Release.
Voltage-gated Ca 2ϩ channels of VSMCs in the different vascular territories can be regulated by numerous vasomotor agents (2, (14) (15) (16) (17) ; hence, we sought synergistic interactions between some of these agents and CCICR. In voltage-clamped myocytes bathed in Ca 2ϩ -free medium that responded to step membrane depolarization with only a small increase or no change of cytosolic [Ca 2ϩ ], the presence of extracellular ATP resulted in a marked augmentation of CCICR amplitude (Fig. 1A Left) . Cells selected for these experiments were either unresponsive to ATP (10-100 M) or showed only a minor Ca 2ϩ response to the nucleotide at the holding potential of Ϫ70 mV. Application in the same cells of NE or acetylcholine (ACh), agents without vasoconstrictive action on the basilar artery (18, 19) , failed to produce any effect on CCICR (n ϭ 9) (Fig. 1 A Right) . Both the depolarization-induced Ca 2ϩ signal and its potentiation by extracellular ATP disappeared when the SR Ca 2ϩ store was depleted by the addition of caffeine (Fig. 1B) . Blockade of the G protein͞PLC cascade with intracellular GDP␤S (1 mM), which completely suppresses CCICR (6), also abolished the potentiation by ATP (n ϭ 4 cells tested). CCICR signals evoked by step depolarizations appeared with a latency of several seconds, probably reflecting the time required to synthesize sufficient InsP 3 to release Ca 2ϩ from the SR (Fig. 1C ). This latency (measured as the time to reach the peak of the Ca 2ϩ signal) was voltagedependent and varied from 15.9 Ϯ 2 s (n ϭ 7) for small depolarizations (from Ϫ70 mV to membrane voltages between Ϫ30 and Ϫ10 mV) to 8.5 Ϯ 1 s, (n ϭ 12) for larger depolarizations (from Ϫ70 mV to potentials between ϩ30 and ϩ50 mV) (P Ͻ 0.05). Exposure to ATP significantly reduced the duration of the latency and increased the amplitude of the Ca 2ϩ spike (Fig. 1D) , thus further suggesting potentiation of CCICR by ATP.
Because, in the absence of membrane depolarization, CCICR can be triggered by pharmacological activation of Ca 2ϩ channels with 2,5-dimethyl-4-[2-(phenylmethyl)benzoil]-1H-pyrrole-3-carboxylic acid methyl ester (FPL)-64176, a well known Ca 2ϩ channel agonist (20) (21) (22) , we tested to see the interaction between FPL and ATP. In intact cells where FPL or ATP alone evoked only small Ca 2ϩ signals, simultaneous exposure to both agents markedly increased the amplitude of the Ca 2ϩ spikes independently of their order of application ( Fig. 2 A-C) . Therefore, these data indicate that ATP potentiates CCICR evoked by either step membrane depolarization or FPL.
Direct and Selective Activation of L-Type Ca 2؉ Channels by ATP in
Arterial Myocytes. Because CCICR requires Ca 2ϩ channel activation, we investigated the effect of ATP on the macroscopic voltagedependent Ca 2ϩ currents recorded in patch-clamped myocytes. These currents were unaffected by NE (10 M, n ϭ 7) (Fig. 3A) or ACh (10 M, n ϭ 6), agents that, as shown above (see Fig. 1 A) , did not influence the CCICR signals (Table 1) . However, in the same cells, ATP (10 M) elicited an increase in the amplitude of the Ca 2ϩ currents of Ϸ30-40% in the entire range of membrane potentials ( Fig. 3 A and B) . At ϩ20 mV, the peak Ca 2ϩ current increased significantly in the presence of ATP and was almost completely blocked by nifedipine (Table 1) . Besides the increase in the Ca 2ϩ conductance, ATP accelerated activation and slowed inactivation and closing kinetics (see Fig. 5 , which is published as supporting information on the PNAS web site). To further evaluate the specificity of the effect of ATP on rat basilar myocytes, we tested the action of endothelin-1 (ET-1), an efficacious constrictor in the basilar artery (23, 24) . ET-1 had no significant effect on the amplitude of the macroscopic Ca 2ϩ current (Fig. 3C) . Peak Ca 2ϩ current amplitude recorded during depolarizations to ϩ20 mV before and after application of ET-1 (5-10 nM) were 99.6 Ϯ 16.9 pA and 98.8 Ϯ 19.8 pA, respectively (n ϭ 5). In these same cells, current amplitude significantly increased in the presence of ATP (10 M; 170.9 Ϯ 26.9 pA). To distinguish between a possible direct effect of ATP on Ca 2ϩ channels and the indirect modulation mediated by activation of metabotropic P 2Y receptors, we performed experiments using the ATP-receptor antagonist suramin (25 M) . This concentration was sufficient to block 93 Ϯ 5% of the Ca 2ϩ -release signal in intact cells (n ϭ 22), where ATP (10 M) produced a large Ca 2ϩ transient. Nevertheless, suramin neither had an effect on the amplitude of the Ca 2ϩ current nor prevented the increase of current amplitude induced by ATP ( Fig. 3D and Table  1 ). Moreover, simultaneous addition of suramin and pyridoxal phosphate 6-azophenyl-2Ј,4Ј-disulfonic acid (another P2 antagonist) (17) yielded similar results (see Fig. 6A , which is published as supporting information on the PNAS web site). The reversible augmentation of Ca 2ϩ current amplitude by ATP occurred in cells dialyzed with 1 mM GDP␤S (Fig. 3E , Table 1 ) and was not mimicked by either other adenine nucleotides (ADP) or the P 2Y receptor agonist UTP (Fig. 3F , Table 1 ). However, the nonhydroxylable analogue ATP␥S produced a current potentiation similar to ATP (see Fig. 6B ). As expected, ATP markedly enhanced the FPL-induced activation of Ca 2ϩ channels ( Fig. 3 G and H) . These data strongly suggest that, in basilar myocytes, ATP enhances Ca 2ϩ current amplitude through direct interaction with the channels, thus explaining the potentiation of CCICR described in the preceding section. This effect of ATP on vascular L-type Ca 2ϩ channels does not seem to be restricted to basilar myocytes, because it was also observed with similar characteristics (Ϸ40% increase of peak Ca 2ϩ -current amplitude at ϩ20 mV, n ϭ 5) in experiments performed on dispersed pulmonary artery myocytes.
Extracellular ATP Potentiates Contraction Induced by CCICR in Intact
Arterial Rings. Because CCICR can induce contraction in isolated basilar myocytes (6), we studied whether the metabotropic activation of Ca 2ϩ channels can, indeed, produce contraction in intact arterial rings and whether ATP can modulate the CCICRdependent vasomotor responses. Exposure of basilar arterial rings to a depolarizing solution with 70 mM K ϩ produced a powerful and reversible contractive response (7.02 Ϯ 0.37 mN, n ϭ 8). Although it is generally thought that much of the K ϩ -induced contractility depends on extracellular Ca 2ϩ influx, it is noteworthy that the response to high K ϩ was not completely abolished by using external solutions without Ca 2ϩ plus 0.2-0.5 mM EGTA (0Ca solution). In these conditions, depolarization with 70 mM K ϩ produced an appreciable vasoconstriction of Ϸ1͞3 the amplitude of that produced with normal extracellular [Ca 2ϩ ] (2.4 Ϯ 0.5 mN, n ϭ 9) (Fig.  4A) . To ascertain what signal (either membrane depolarization per se or Ca 2ϩ channel activation) triggers SR Ca 2ϩ release and contraction of basilar arterial rings, we performed experiments with FPL. Pharmacological activation of Ca 2ϩ channels with FPL elicited a powerful contraction of arterial rings (7.01 Ϯ 1.9 mN, n ϭ 21), which was partially preserved (2.85 Ϯ 0.38 mN, n ϭ 23) after removal of extracellular Ca 2ϩ (Fig. 4B) . Interestingly, the FPLinduced arterial contraction almost disappeared (Ϸ95% inhibition, n ϭ 5) in the presence of U73122 (1-5 M), a selective blocker of PLC (25) without effects on Ca 2ϩ currents (Fig. 4C) . The isoform U73433, inactive on the enzyme, did not alter the FPL-dependent contraction. These observations indicate that, in the absence of extracellular Ca 2ϩ influx, FPL can produce vasoconstriction due to Ca 2ϩ release from internal stores. Because FPL activates Ca 2ϩ channels without primarily altering the membrane potential, the data strongly suggest that it is Ca 2ϩ channel activation, independent of any change in membrane voltage, that induces Ca 2ϩ release and vasoconstriction.
Given that a significant fraction of L-type Ca 2ϩ channeldependent contraction in arterial myocytes seems to be mediated through CCICR, we investigated, in arterial rings, the interaction between ATP and CCICR described in isolated myocytes. First, we analyzed the contractive responses of arterial rings exposed to low concentrations of ATP (1-10 M) and 40 mM K ϩ . It was tested before that, with this concentration of extracellular K ϩ , the membrane potential of isolated patch-clamped myocytes was depolarized to Ϫ25.4 Ϯ 5.2 mV (n ϭ 5) and that, at high concentrations, ATP contracted arterial rings (2.9 Ϯ 1.6 mN; n ϭ 47). Although low concentrations of ATP (1 M) generally failed to evoke any arterial-ring contraction, the isometric force induced by 40 K ϩ (3.3 Ϯ 0.5 mN) was significantly increased (4.9 Ϯ 0.56 mN, n ϭ 15) in the presence of ATP, even after purinergic-receptor blockade with suramin (Fig. 4D) . Note that there was no statistically significant difference between the contraction induced by 40 K ϩ in the presence and absence of suramin. These experiments on arterial rings indicate that, in fair agreement with the data in single cells, isometric force elicited by 40 K ϩ -induced depolarization is markedly potentiated by small concentrations of ATP, below those required to evoke vasoconstriction.
Because ATP can enhance the FPL-dependent potentiation of both Ca 2ϩ currents and Ca 2ϩ release in isolated myocytes (see Figs.  2 and 3) , we also analyzed the interaction between these agents using arterial rings. In the absence of extracellular Ca 2ϩ , ATP reversibly increased the vasoconstriction induced by FPL (Fig. 4E) . This additive effect of FPL and ATP was observed even with concentrations of the two agents below those required to induce a contractive response separately. In contrast, vasoconstriction induced by FPL was not potentiated by the simultaneous addition of small concentrations of ET-1 (data not shown), which is compatible with the lack of effect of ET-1 on the macroscopic Ca 2ϩ current in basilar myocytes (see Fig. 3C ). Because FPL induced Ca 2ϩ release in the absence of membrane depolarization (6), these data further support the view that ATP can potentiate FPL-induced CCICR and, thus, arterial ring contraction without the need of large changes in membrane voltage.
Discussion
The main observations in this study are: (i) CCICR is markedly and selectively increased by extracellular ATP; (ii) the effect of ATP is mediated through the direct activation of Ca 2ϩ channels, leading to Ca 2ϩ release from the SR and vasoconstriction; (iii) CCICR, a phenomenon studied before in isolated arterial myocytes (6), can elicit contraction in arterial basilar rings in the absence of extracellular Ca 2ϩ and is potentiated by ATP; and (iv) the interaction among ATP, membrane depolarization, and CCICR represents a new form of eliciting arterial-myocyte contraction, even in the absence of Ca 2ϩ channel opening, which could contribute to pathophysiological conditions presenting persistent vasoconstriction.
We have shown that CCICR, indeed, has physiological significance, because it is differentially modulated by vasoactive agents. NE is known to increase the open probability of Ca 2ϩ channels in mesenteric myocytes (14) and increased Ca 2ϩ currents in rabbit ear artery (15) . However, the effect of NE varies in different vascular territories, because we have observed that NE (up to 10 M) does not influence the contractility of the basilar arterial rings and the absence effect of this drug on the basilar artery studied in vivo has been reported (26) . In accord with these results, we have also shown that NE has no effect on Ca 2ϩ currents in basilar myocytes and, therefore, does not modulate CCICR. ACh, a vasoactive agent in some vascular territories (27, 28) , and ET-1, an efficacious constrictor in the rat basilar artery (24) , also failed to induce potentiation of CCICR or Ca 2ϩ currents in our preparation. In contrast, ATP, a vasoactive agent in the mammalian cerebral circulation (12, 13, 29) , exerts a powerful facilitatory role on CCICR and rat basilar myocyte contractility. ATP is known to elicit, in VSMCs, either Ca 2ϩ influx through ligand-gated calcium channels or Ca 2ϩ release due to activation of metabotropic P 2Y receptors (3, 30) . These effects of ATP are abolished by blockade of the receptors with suramin or pyridoxal phosphate 6-azophenyl-2Ј,4Ј,-disulfonic acid, in the case of effects mediated by P 2Y receptors, or after G protein inhibition by the intracellular application of GDP␤S. Interestingly, we describe here that, after blockade of purinergic receptors, ATP (even at subthreshold concentration) reversibly increases Ca 2ϩ -current amplitude and, in the absence of extracellular Ca 2ϩ , enhances CCICR and, subsequently, arterial contractility. These phenomena appear to be highly selective, because other nucleotides (ADP or UTP) or the vasoactive agents tested (NE, ACh, or ET-1) did not produce the same effect as ATP. ATP and FPL had an additive effect on myocyte Ca 2ϩ channels, thus suggesting that they act through separate mechanisms to increase the macroscopic current amplitude. ATP's effects on Ca 2ϩ channels were unaltered by intracellular dialysis with GDP␤S but were mimicked by extracellular ATP␥S. Altogether, these data strongly suggest that ATP directly interacts with a receptor site in the channel molecule to favor Ca 2ϩ channel activation. A qualitatively similar phenomenon has been observed in ventricular myocytes, where direct interaction of ATP with the channels was suggested, because the effect was maintained in single L-type Ca 2ϩ channels reconstituted into planar lipid bilayers (31, 32) . Therefore, two observations in our study are the direct and selective facilitatory effect of ATP on L-type Ca 2ϩ currents in vascular myocytes and, more significantly, the potentiation of CCICR by ATP. CCICR is inhibited by nifedipine and other Ca 2ϩ antagonists (6), thus explaining why ATP-induced Ca 2ϩ release in basilar myocytes is abolished after application of these drugs (3) .
Besides the effect of ATP on myocyte Ca 2ϩ channels, we have demonstrated that, without extracellular Ca 2ϩ influx, basilar arterial smooth muscle can contract in response to Ca 2ϩ channel activation by either membrane depolarization or direct pharmaco- 
The data show the effect of ACh, NE, ATP, UTP, ADP, nifedipine, and suramin (added to the external solution; concentrations are in parentheses) and GDP␤S (1 mM; added to the internal solution) on macroscopic Ca 2ϩ currents (expressed in pA as mean Ϯ SE). Experiments were done in voltage-clamped myocytes, and current was measured at the end of the depolarizing pulses to ϩ20 mV from a holding potential of Ϫ70 mV. Asterisks indicate statistically significant differences with respect to the values obtained with control solutions. nifed, nifedipine. logical modulation. These results agree with previous studies in intestine (33) , aorta (34), coronary artery (35), human umbilical artery (36) , and portal vein (37) , in which contraction of smooth muscle cells by a Ca 2ϩ -free depolarizing solution was reported. Contraction of the basilar artery elicited upon Ca 2ϩ channel activation does not necessarily require membrane depolarization, because FPL, a Ca 2ϩ channel agonist that directly modifies Ca 2ϩ channel gating, (20) (21) (22) also produced contraction of arterial rings bathed in Ca 2ϩ -free solution. These findings are in excellent agreement with the data obtained in single myocytes, demonstrating that CCICR (the coupling of Ca 2ϩ channels to the SR through the activation of the PLC͞InsP 3 pathway) can be triggered by either membrane depolarization or FPL. The CCICR helps to explain the dependence of InsP 3 -dependent Ca 2ϩ release on the membrane potential observed in smooth muscle (8, 9) and other cell types (7, 10) ; however, the possibility that there is a voltage-dependent step at the level of either G protein or PLC activation (8-10) cannot be fully excluded.
The potentiation of CCICR and vasoconstriction by ATP described in this article might have a significant role in physiological and pathophysiological conditions presenting myocyte depolarization and increase of external ATP concentration. ATP is coreleased with NE from sympathetic terminals and also from cells (erythrocytes and platelets) that are damaged during vascular injury (11) (12) (13) . In this regard, a most representative condition is the delayed cerebral vasoconstriction characteristic of patients with subarachnoid hemorrhage (SAH). Although the cause of this type of cerebral vasospasm is likely of multiple origin, there is a wealth of data suggesting that ATP released from blood clots (erythrocytes and platelets) might have an important contribution (13, 38, 39) . We have shown here that, at concentrations that cannot evoke contraction, ATP potentiates both CCICR and the vasoconstriction induced by depolarization with high K ϩ . It has been shown that, in experimental SAH, cerebral arterial myocytes are depolarized (40, 41) therefore, it is possible that the conjunction of membrane depolarization and ATP release (12, 13 ) (even at low concentrations) leads to cerebral vasospasm. The fact that organic Ca 2ϩ channel antagonists inhibit not only extracellular Ca 2ϩ influx but also CCICR (6) would explain the beneficial effect of these drugs in the prevention or treatment of ischemia secondary to SAH (42) . In conclusion, our data support the view that L-type Ca 2ϩ channels in basilar VSMCs are not only mediators of Ca 2ϩ influx, but they also have a metabotropic action, leading to Ca 2ϩ release from the SR. This metabotropic effect of Ca 2ϩ channels, markedly potentiated by even low concentration of ATP acting directly on Ca 2ϩ channels, could contribute to vascular pathophysiology. 43 . Voltage-and current-clamp recordings were performed by using the whole-cell configuration of the patch-clamp technique (6, 43) . When cytosolic [Ca 2ϩ ] and membrane holding potential or current were recorded simultaneously, the signals were digitized at a sampling interval of 500 ms and filtered at 3 KHz. Ca 2ϩ currents were digitized by using a sample interval of 50 s. All the experiments were performed at room temperature (Ϸ22°C).
Solutions. The composition of Hanks' solution was 125 mM NaCl, 5.36 mM KCl, 5 mM NaHCO 3 , 0.34 mM Na 2 HPO 4 , 0.44 mM KH 2 PO 4 , 10 mM glucose, 1.45 mM sucrose, and 10 mM Hepes, pH 7.4. The recording chamber was continuously superfused with a standard external solution with 140 mM NaCl, 2.7 mM KCl, 2.5 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM Hepes, pH 7.4. Unless otherwise noted, all the drugs used were added to this solution at the indicated concentration. The 70 mM K ϩ solution was obtained by replacing 70 mM of NaCl with KCl. The 0Ca solution was obtained by substituting Mg 2ϩ for Ca 2ϩ and with 2 mM EGTA added. Cytosolic Ca 2ϩ measurements and patch-clamp recordings were done by dialyzing the cells with a standard internal solution containing 83 mM potassium glutamate, 47 mM KCl, 1 mM MgCl 2 , 10 mM Hepes, 4 mM ATP-Mg, and 50 M Fura 2-potassium salt, pH 7.2. To record whole-cell Ca 2ϩ currents, the solutions used were as follows: external (140 mM NaCl, 2.7 mM KCl, 10 mM BaCl 2 , and 10 mM Hepes, pH ϭ 7.4); and internal (100 mM CsCl, 30 mM CsF, 2 mM MgCl 2 , 4 mM ATP-Mg, 10 mM EGTA, and 10 mM Hepes, pH 7.2).
Measurement of Contractility in Arterial Rings. Basilar arteries were cleaned of connective tissue, cut in rings (Ϸ2 mm) and mounted on a small-vessel myograph (JP Trading, Aarhus, Denmark) to measure isometric tension connected to a digital recorder (Myodataq-2.01, Myodata-2.02 Multi Myograph System). The rings were placed on a chamber filled with the standard external solution (10 mM glucose added) and bubbled with 95% O 2 and 5% CO 2 at pH 7.4. Before the experiments, the segments were subjected to an optimal tension (90% of tension equivalent to an intramural pressure of 100 mm Hg) and stabilized for at least 30 min. For Ca 2ϩ -free solution, CaCl 2 was omitted, and 200-500 M EGTA was added. After the equilibration period, we discarded arterial rings that developed a tension of Ͻ1 mN in response to KCl (40-70 K ϩ ). Experiments in the absence of Ca 2ϩ were done after incubating arterial rings in Ca 2ϩ -free solution for 15 min and washing the external solution at least four times. All the drugs used were added directly to the chamber while vessel tension was monitored. Experiments were performed at 37°C.
Statistical Analysis. Data are expressed as mean Ϯ SE, and the statistical significance was estimated by using the Student t test. Values of P Ͻ 0.05 were considered significant. 
